Literature DB >> 9642641

Pseudopapilledema and congenital disc anomalies in growth hormone deficiency.

P F Collett-Solberg1, G T Liu, M Satin-Smith, L L Katz, T Moshang.   

Abstract

Optic nerve hypoplasia is a congenital disc anomaly associated with growth hormone deficiency (GHD). Pseudotumor cerebri is an adverse event associated with growth hormone treatment (hGH) and manifested by increased intracranial pressure and papilledema. Pseudopapilledema is a generic ophthalmologic term encompassing several conditions, including congenital disc anomalies. It is benign and can be distinguished from papilledema by physical examination. The objective of this report is to document that congenital disc abnormalities, which can be confused with papilledema, occur in children with GHD. Three patients with GHD had fundoscopic examinations suggestive of papilledema and possibly pseudotumor cerebri. The abnormal optic nerves were characteristic of pseudo-papilledema, and appear to be a variant of optic nerve hypoplasia. The finding of optic disc abnormality during hGH may reflect pseudo-papilledema and not pseudotumor cerebri. Of equal importance, the reported patients indicate that the finding of pseudopapilledema in short children should suggest the possibility of GHD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9642641     DOI: 10.1515/jpem.1998.11.2.261

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  7 in total

1.  New-Onset Isolated Asymptomatic Papilledema in Two Patients Treated With Recombinant Growth Hormone.

Authors:  Lauren Amanda Kanner; Jason Klein; Majida Gaffar; Howard Pomeranz; Graeme Frank
Journal:  Clin Pediatr (Phila)       Date:  2017-03-22       Impact factor: 1.168

2.  Choroidal thickness measurements in children with isolated growth hormone deficiency.

Authors:  N G Yalcin; Z Aktas; O Yuce; G D G Ikiz; M Hasanreisoglu; A Bideci
Journal:  Eye (Lond)       Date:  2017-09-15       Impact factor: 3.775

3.  Corneal properties in children with congenital isolated growth hormone deficiency.

Authors:  Pinar Nalcacioglu-Yuksekkaya; Emine Sen; Ufuk Elgin; Mumin Hocaoglu; Faruk Ozturk; Sebahat Agladıoglu Yilmaz; Havva Nur Kendirci; Semra Cetinkaya; Zehra Aycan
Journal:  Int J Ophthalmol       Date:  2014-04-18       Impact factor: 1.779

4.  Evaluation of central corneal and central retinal thicknesses and intraocular pressure in acromegaly patients.

Authors:  Sefika Burcak Polat; Nagihan Ugurlu; Reyhan Ersoy; Oguzhan Oguz; Necati Duru; Bekir Cakir
Journal:  Pituitary       Date:  2014-08       Impact factor: 4.107

5.  Retinal Neural and Vascular Structure in Isolated Growth Hormone Deficiency Children and Evaluation of Growth Hormone Treatment Effect

Authors:  Özge Yüce; Nuriye Gökçen Yalçın; Aysun Bideci; Esra Döğer; Hamdi Cihan Emeksiz; Murat Hasanreisoğlu; Zeynep Aktaş; Orhun Çamurdan; Peyami Cinaz
Journal:  J Clin Res Pediatr Endocrinol       Date:  2017-10-30

6.  OTUD5 Variants Associated With X-Linked Intellectual Disability and Congenital Malformation.

Authors:  Ken Saida; Tokiko Fukuda; Daryl A Scott; Toru Sengoku; Kazuhiro Ogata; Annarita Nicosia; Andres Hernandez-Garcia; Seema R Lalani; Mahshid S Azamian; Haley Streff; Pengfei Liu; Hongzheng Dai; Takeshi Mizuguchi; Satoko Miyatake; Miki Asahina; Tsutomu Ogata; Noriko Miyake; Naomichi Matsumoto
Journal:  Front Cell Dev Biol       Date:  2021-03-03

7.  Quantitative measures of the vascular and neural components of the retina in adult individuals with congenital and untreated growth hormone deficiency.

Authors:  Nelmo V Menezes; Cynthia S Barros-Oliveira; Roberto Salvatori; Vinicius C Gois; Cindi G Marinho; Carla R P Oliveira; Viviane C Campos; Alécia A Oliveira-Santos; Hertz T Santos-Júnior; Elenilde G Santos; Enaldo V Melo; Augusto C N Faro; Neima V Oliveira; Hérika M Gumes-Felix; Gustavo B Melo; Manuel H Aguiar-Oliveira
Journal:  Int J Retina Vitreous       Date:  2022-10-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.